|
| 1 |
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65. Published online 2023 April 7
DOI: http://dx.doi.org/10.5045/br.2023.2023035
|
|
| 2 |
Prognostic impact of total body irradiation dose in pediatric acute lymphoblastic leukemia patients treated with allogeneic hematopoietic stem cell transplantation in second complete remission
Wonjin Jang, Suejung Jo, Jae Won Yoo, Seongkoo Kim, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho
Blood Res.2022;57(4):256-263. Published online 2022 December 31
DOI: http://dx.doi.org/10.5045/br.2022.2022174
|
|
| 3 |
Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?
Gi-June Min, Byung-Sik Cho, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Seung-Ah Yahng, Seung-Hawn Shin, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Blood Res.2022;57(3):197-206. Published online 2022 September 30
DOI: http://dx.doi.org/10.5045/br.2022.2022060
|
|
| 4 |
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
J Liver Cancer.2022;22(1):63-68. Published online 2022 February 14
DOI: http://dx.doi.org/10.17998/jlc.2022.01.18
|
|
| 5 |
Predictors of Diagnostic Contributions and Spontaneous Remission of Symptoms Associated with Positron Emission Tomography with Fluorine-18-Fluorodeoxy Glucose Combined with Computed Tomography in Classic Fever or Inflammation of Unknown Origin: a Retrospective Study
Seiichiro Tsuzuki, Ayumi Watanabe, Mitsunaga Iwata, Hiroshi Toyama, Teruhiko Terasawa
|
|
| 6 |
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali
Intest Res.2021;19(2):171-185. Published online 2021 February 3
DOI: http://dx.doi.org/10.5217/ir.2020.00035
|
|
| 7 |
Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey
Jieun Uhm, Kyoung Ha Kim, Hyewon Lee, Hawk Kim, Slader Cassandra, Inkyung Joo, Chul Won Jung
Blood Res.2021;56(1):31-37. Published online 2021 January 28
DOI: http://dx.doi.org/10.5045/br.2021.2020260
|
|
| 8 |
Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
Intest Res.2022;20(1):90-100. Published online 2021 January 22
DOI: http://dx.doi.org/10.5217/ir.2020.00133
|
|
| 9 |
Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, Deng-Chyang Wu, Suk-Kyun Yang, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res.2021;19(1):83-94. Published online 2020 December 31
DOI: http://dx.doi.org/10.5217/ir.2019.09160
|
|
| 10 |
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res.2021;19(1):71-82. Published online 2020 September 4
DOI: http://dx.doi.org/10.5217/ir.2019.09159
|
|
| 11 |
Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Alexandra Cohen, Najma Ahmed, Ana Sant’Anna
Intest Res.2021;19(2):217-224. Published online 2020 April 22
DOI: http://dx.doi.org/10.5217/ir.2019.09164
|
|
| 12 |
Current Treatments on Obesity
Chul Jin Lee, Min-Jeong Kim, Sang Joon An
|
|
| 13 |
Natural History of Chronic Urticaria in Korea
Bo Young Chung, Ji-young Um, Seok Young Kang, Hye One Kim, Chun Wook Park
Ann Dermatol.2020;32(1):38-46. Published online 2019 December 27
DOI: http://dx.doi.org/10.5021/ad.2020.32.1.38
|
|
| 14 |
Medical Treatment of Graves' Disease
Hyun-Kyung Chung
|
|
| 15 |
Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan
Tadahiro Yanagi, Kosuke Ushijima, Hidenobu Koga, Takeshi Tomomasa, Hitoshi Tajiri, Reiko Kunisaki, Takashi Isihige, Hiroyuki Yamada, Katsuhiro Arai, Atsushi Yoden, Tomoki Aomatsu, Satoru Nagata, Keiichi Uchida, Yoshikazu Ohtsuka, Toshiaki Shimizu
Intest Res.2019;17(4):476-485. Published online 2019 August 31
DOI: http://dx.doi.org/10.5217/ir.2019.00027
|
|
| 16 |
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
Byungsoo Kim, Emanual Maverakis, Siba P. Raychaudhuri
Ann Dermatol.2019;31(5):495-501. Published online 2019 August 30
DOI: http://dx.doi.org/10.5021/ad.2019.31.5.495
|
|
| 17 |
Graves' Disease: Can It Be Cured?
Wilmar M. Wiersinga
|
|
| 18 |
A case of endodermal sinus tumor of ovary: Complete remission & full-term delivery after conservative surgery and BEP therapy
Woo Gyeong Kim, Kyung Bok Lee, Moon Su Sung, Ki Tae Kim, Hyun Chan Kim
|
|
| 19 |
Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature
Yong-Sung Choi, Jong Kyu Kim, Wan Jung Kim, Mi-Jung Kim
Intest Res.2019;17(2):273-277. Published online 2019 February 12
DOI: http://dx.doi.org/10.5217/ir.2018.00122
|
|
| 20 |
Comparison of Renal Responses to Cyclophosphamide and Mycophenolate Mofetil used as Induction Therapies in Korean Patients with Lupus Nephritis
Sung-Eun Choi, Dong-Jin Park, Ji-Hyoun Kang, Kyung-Eun Lee, Haimuzi Xu, Ji Shin Lee, Yoo-Duk Choi, Shin-Seok Lee
J Rheum Dis.2019;26(1):57-65. Published online 2019 January 31
DOI: http://dx.doi.org/10.4078/jrd.2019.26.1.57
|
|
